m.Stock by Mirae AssetOpen Demat Account
m.Stock by Mirae Asset

IPOAsston Pharmaceuticals Ltd IPO

  • Price Range

    ₹115 - ₹123

  • Min. Quantity

    2,000 Shares

  • Closes on

    11 July 2025

  • Min. investment

    ₹2,46,000

Asston Pharmaceuticals Ltd IPO Timeline

EventDate
Asston Pharmaceuticals Ltd IPO Opening Date9 July 2025
Asston Pharmaceuticals Ltd IPO Closing Date 11 July 2025
Basis of Allotment14 July 2025
Initiation of Refunds15 July 2025
Credit of Shares to Demat15 July 2025
Asston Pharmaceuticals Ltd IPO Listing Date16 July 2025

Asston Pharmaceuticals Ltd IPO Details

Asston Pharmaceuticals Ltd IPO Date9 July 2025 to 11 July 2025
Asston Pharmaceuticals Ltd IPO Face Value₹10 per share
Asston Pharmaceuticals Ltd IPO Price₹115 to ₹123 per share
Asston Pharmaceuticals Ltd IPO Lot Size2,000
Issue Size Shares of ₹10 (aggregating up to ₹27.56 Cr)
Fresh Issue Shares of ₹10 (aggregating up to ₹27.56 Cr)
Offer for Sale-
Issue TypeBook Building - SME
Listing At BSE - SME
QIB Shares OfferedNot more than 4,25,000 of the Net Offer
Retail Shares OfferedNot less than 7,46,000 of the Net Offer
NII (HNI) Shares OfferedNot less than 3,22,000 of the Net Offer
Company PromotersAshish Narayan Sakalkar, Saili Jayaram More, Sachin Chandrakant Badakh

Asston Pharmaceuticals Ltd IPO Lot Size

The Asston Pharmaceuticals Ltd IPO lot size is 2,000 shares. A retail-individual investor can apply for up to 0 lots (0 shares or ₹0).

Application LotsSharesAmount
Minimum12,000₹2,46,000
Maximum-0₹0
  • Risks
  • Opportunities
  • Formulation Expertise.
  • Experienced Promoters.
  • Wide range of Products.
  • Strategic Location.
  • Skilled Workforce.
  • Good relationship with contract manufacturers.
  • Quality Assurance.
  • Good relationship with clients in the export market.
  • Competitive Pricing.
  • Asset Light Model.

Company Financials

Asston Pharmaceuticals Ltd Financial Information (Restated)

Period Ended Total AssetsTotal RevenueProfit After Tax
03-202528.1325.613.85
03-202420.2615.841.36
03-202313.697.191.06
Amount in ₹ Crore

Objects of the Issue

The company proposes to utilise the Net Proceeds from the Fresh Issue towards funding the following objects:

  • Funding capital expenditure requirements towards acquiring machinery in the manufacturing unit
  • Funding the incremental working capital requirements of our company
  • Repayment and/or prepayment, in part or full, of certain of our outstanding borrowings availed by our company.
  • General corporate purposes

Asston Pharmaceuticals Ltd IPO Promoter Holding

Pre Issue Share Holding29.54%
Post Issue Share Holding21.77%

Asston Pharmaceuticals Ltd IPO Subscription Status (Bidding Detail)

The Asston Pharmaceuticals Ltd IPO is subscribed 124.3601 times on 11 July 2025 05:00:00 PM. The public issue subscribed 172.1394 times in the retail category, 85.7624 times in the QIB category, and 353.4969 times in the NII category. Check Day by Day Subscription Details (Live Status)

CategoryQIBNIIRetailEmployeeTotal
Subscription (times)85.7624353.4969172.1394-124.3601

Asston Pharmaceuticals Ltd IPO Prospectus

Asston Pharmaceuticals Ltd IPO Listing Date

BSE Script
NSE Symbol
Listing In BSE - SME
ISININE0SJX01015
IPO Price₹-
Face Value-

Company Contact Information

Asston Pharmaceuticals Ltd
4th Flr Office No.A-431 BalajiBhavan Plot No.42A Sec-11 CBD,Mumbai-400614
Phone: +91 22 4973 1411/+91 22 4973 1419
Email: info@asstonpharmaceuticals.com
Website: www.asstonpharmaceuticals.com

Asston Pharmaceuticals Ltd IPO Registrar

Phone:+91 11 47581432
Email: ipo@maashitla.com
Website: www.maashitla.com

Asston Pharmaceuticals Ltd IPO Lead Manager(s)

  1. Sobhagya Capital Options Pvt. Ltd.

How to Check the Allotment Status of Asston Pharmaceuticals Ltd IPO?

To check the IPO allotment status, follow these steps:

  • Visit the official website of the IPO registrar.
  • Navigate to the IPO Allotment Status page.
  • Select “Asston Pharmaceuticals Ltd” from the list of available IPOs.
  • Enter any one of these - PAN Number, Application Number, DP/Client ID.
  • Click on Submit to view your allotment status.
  • Alternatively, you can also check the allotment status on the stock exchange websites such as NSE or BSE.
  • About Asston Pharmaceuticals Ltd IPO

    Asston Pharmaceuticals Limited was incorporated on 16th April 2019 as 'Asston Pharmaceutical Pvt. Limited' to contract produce pharmaceutical products for export market. Later on 1st April 2024, Company acquired Ferron Lifecare Private Limited, specializing into nutraceuticals business and produced nutraceutical products at their Ambarnath facility. Ferron Lifecare Private Limited, incorporated on 30th January 2020. Finally, 'Asston Pharmaceuticals Private Limited' was converted into a Public Limited Company in the name of 'Asston Pharmaceuticals Limited' on 29th August 2024 and received FDA approval for its Ambarnath facility on 2nd December 2024 to produce pharmaceutical products.

    FAQ